ESMO 2022 Conference Coverage
Video Player is loading.
ESMO 2022 on Doxorubicin Eluting Embolotherapy for Desmoid Fibromatosis
By
ESMO 2022 Conference Coverage
FEATURING
Eldad Elnekave
By
ESMO 2022 Conference Coverage
FEATURING
Eldad Elnekave
Comments 0
Login to view comments.
Click here to Login
